title: Comments on 'Generalized erythroderma and palmoplantar hyperkeratosis in a patient receiving TNF-alpha antagonist therapy'.
authors.affiliation: Departments of Dermatology and Pathology, Northwestern University Feinberg Medical School, Chicago, IL, USA.
authors.forename: Maria Estela
authors.initials: ME
authors.lastname: Martinez-Escala
authors.forename: Joan
authors.initials: J
authors.lastname: Guitart
mesh_terms: D000893:Anti-Inflammatory Agents / Q000009:adverse effects*; D000911:Antibodies, Monoclonal / Q000009:adverse effects*; D061067:Antibodies, Monoclonal, Humanized / Q000009:adverse effects*; D003875:Drug Eruptions / Q000473:pathology*; D005260:Female; D006801:Humans; D007074:Immunoglobulin G / Q000009:adverse effects*; D008297:Male; D014409:Tumor Necrosis Factor-alpha / Q000037:antagonists & inhibitors*
chemical_list: D000893:Anti-Inflammatory Agents; D000911:Antibodies, Monoclonal; D061067:Antibodies, Monoclonal, Humanized; D007074:Immunoglobulin G; D014409:Tumor Necrosis Factor-alpha
keywords: TNF-alpha; cutaneous T-cell lymphoma; erythroderma; peripheral blood; psoriasiform dermatitis